Possible role of IL-25 in eosinophilic lung inflammation in patients with eosinophilic pneumonia

S. Katoh (Okayama, Japan)

Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Session: "Alarming" immunological patterns in asthma
Session type: Poster Discussion
Number: 584
Disease area: Airway diseases, Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Katoh (Okayama, Japan). Possible role of IL-25 in eosinophilic lung inflammation in patients with eosinophilic pneumonia. 584

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Apoptotic response of eosinophils in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 17: 190-194
Year: 2001



Clinical implication of interleukin-33 in acute eosinophilic pneumonia compared with chronic eosinophilic pneumonia
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011

Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease
Source: Eur Respir Monogr 2022; 95: 219-237
Year: 2022


The pathological feature of airway inflammation in eosinophilic bronchitis
Source: Eur Respir J 2005; 26: Suppl. 49, 282s
Year: 2005

The importance of eosinophilic inflammation in COPD exacerbations
Source: International Congress 2017 – COPD management
Year: 2017

Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

Role of neutrophils in airway inflammation in children with chronic bronchiolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 17s
Year: 2002

Biological role of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019

Bronchial hyper-responsiveness in chronic eosinophilic pneumonia is not correlated uniquely to local eosinophil infiltration
Source: Eur Respir J 2002; 20: Suppl. 38, 315s
Year: 2002

The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010


Bronchiectasis associated with inflammatory bowel disease
Source: Eur Respir Mon 2011; 52: 163-177
Year: 2011


Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008



Diffuse idiopathic pulmonary neuroendocrine hyperplasia, chronic eosinophilic pneumonia, and asthma
Source: Eur Respir J 2009; 34: 1489-1492
Year: 2009


The role of pathogenic bacterial colonisation in neutrophilic airways inflammation in severe asthma
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009

Characteristics of eosinophilic and neutrophilic inflammation of bronchi of the bronchial asthma (BA) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 32s
Year: 2001

Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (5) 2000622; 10.1183/13993003.00622-2020
Year: 2020



Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (6) 2004167; 10.1183/13993003.04167-2020
Year: 2020



Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (6) 2003802; 10.1183/13993003.03802-2020
Year: 2020



Biomarkers of eosinophilic inflammation
Source: Eur Respir Monogr 2022; 95: 37-50
Year: 2022


Eicosanoids and eosinophilic inflammation of airways in stable COPD.
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018